Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo (Q45127736)

9 December 2017

Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo (English)

1 reference

9 December 2017

0 references

Nikola Arsic

1

1 reference

9 December 2017

Serena Zacchigna

2

1 reference

9 December 2017

Lorena Zentilin

3

1 reference

9 December 2017

Genaro Ramirez-Correa

4

1 reference

9 December 2017

Lucia Pattarini

5

1 reference

9 December 2017

Alessandro Salvi

6

1 reference

9 December 2017

Gianfranco Sinagra

7

1 reference

9 December 2017

Mauro Giacca

8

1 reference

9 December 2017

1 November 2004

1 reference

9 December 2017

1 reference

9 December 2017

10

1 reference

9 December 2017

844-854

1 reference

9 December 2017

5

1 reference

Vascular-specific growth factors and blood vessel formation

9 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

The biology of VEGF and its receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Angiogenesis-independent endothelial protection of liver: role of VEGFR-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Expression of vascular endothelial growth factor receptors in smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Reactive oxygen and NF-kappaB in VEGF-induced migration of human vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Long‐term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno‐associated viral vectors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Immune responses to adenovirus and adeno-associated virus in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Vascular endothelial growth factor modulates skeletal myoblast function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Recombinant adeno-associated virus for muscle directed gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

VEGF gene delivery to muscle: potential role for vasculogenesis in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Dystrophin expression in the mdx mouse restored by stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Recombinant adeno-associated virus type 2 mediates highly efficient gene transfer in regenerating rat skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Highly coordinated gene regulation in mouse skeletal muscle regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Experimental glycerol myopathy: a histological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Three types of muscle-specific gene expression in fusion-blocked rat skeletal muscle cells: translational control in EGTA-treated cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Mechanism of activation of protein kinase B by insulin and IGF-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

Recombinant AAV vector encoding human VEGF165 enhances wound healing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.007

10.1016/J.YMTHE.2004.08.007

7 January 2021

Identifiers

DOI

1 reference

9 December 2017

1 reference